Application of normalised resistance interpretation to disc diffusion data on the susceptibility of Aeromonas salmonicida to three quinolone agents

Aquaculture

Volumn 272, Issue 1-4, 2007, Pages 156-167

  Ruane, Neil M ^b   Douglas, Iain ^a   Geary, Michelle ^b   Carroll, Cyril ^a   Fleming, Gerard T A ^a   Smith, Pete ^a  

^a NATIONAL UNIVERSITY OF IRELAND   (Ireland)

^b MARINE INSTITUTE   (Ireland)

Author keywords

Antimicrobial susceptibility; Fish; Interpretative criteria; Normalised resistance interpretation; Quinolones

Indexed keywords

ANTIBIOTIC RESISTANCE; BACTERIUM; FISH; LABORATORY METHOD;

AEROMONAS SALMONICIDA;

EID: 35748932682     PISSN: 00448486     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.aquaculture.2007.08.037     Document Type: Article

References (39)

1. Barnes A.C., Lewin C.S., Hastings T.S., and Amyes S.G. Cross-resistance between oxytetracycline and oxolinic acid in Aeromonas salmonicida associated with alterations in outer membrane proteins. FEMS Microbiology Letters 60 (1990) 337-339
2. CLSI. Development of In Vitro Susceptibility Testing Criteria and Quality Control Parameters for Veterinary Antimicrobial Agents. Approved Guideline M37-A2 (2002), Clinical and Laboratory Standards Institute, Wayne, Pennsylvania
3. CLSI. Methods for Antimicrobial Disk Susceptibility Testing of Bacteria Isolated from Aquatic Animals. Approved Guideline M42-A. (2006), Clinical and Laboratory Standards Institute, Wayne, Pennsylvania
4. CLSI. Methods for Broth Dilution Susceptibility Testing of Bacteria Isolated from Aquatic Animals. Approved Guideline M49-A (2006), Clinical and Laboratory Standards Institute, Wayne, Pennsylvania
5. Endo T., Ogishima K., Hayasakai H., Kaneko S., and Ohshima S. Application of oxolinic acid as a chemotherapeutic agent against infectious diseases - 1. Antibacterial activity, chemotherapeutic effects and pharmacokinetics of oxolinic acid in fishes. . Bulletin of the Japanese Society of Scientific Fisheries 39 (1973) 165-171
6. EUCAST. Terminology Relating to Methods for the Determination of Susceptibility of Bacteria to Antimicrobial Agents. EUCAST Definitive Document E.Def 1.2 May 2000 (2000). http://www.srga.org/Eucastwt/eucastdefinitions.htm http://www.srga.org/Eucastwt/eucastdefinitions.htm.
7. Gibello A., Porrero M.C., Blanco M.M., Vela A.I., Liébana P., Moreno M.A., José F., Fernández-Garayzábal J.F., and Lucas Domínguez L. Analysis of the gyrA gene of clinical Yersinia ruckeri isolates with reduced susceptibility to quinolones. Applied and Environmental Microbiology 70 (2004) 599-602
8. Giraud E., Blanc G., Bouju-Albert A., Weill F.-X., and Donnay-Moreno C. Mechanisms of quinolone resistance and clonal relationship among Aeromonas salmonicida strains isolated from reared fish with furunculosis. Journal of Medical Microbiology 53 (2004) 895-901
9. Goñi-Urriza M., Arpin C., Capdepuy M., Dubois V., Caumette P., and Quentin C. Type II topoisomerase quinolone resistance-determining regions of Aeromonas caviae, A. hydrophila, and A. sobria complexes and mutations associated with quinolone resistance. Antimicrobial Agents and Chemotherapy 46 (2002) 350-359
10. Guichard B., and Licek E. A comparative study of antibiotics registered for use in farmed fish in European countries. Poster Presented at the First OIE Global Conference on Aquatic Animal Health, October 10, Bergen, Norway (2006)
11. Hastings T.S. Chemotherapy of furunculosis. In: Ellis A.E., Bernoth E.M., Midtlyng P., Olivier O., and Smith P. (Eds). Furunculosis in Fish - A Multidisciplinary Review (1997), Academic Press, London 423-432
12. Hastings T.S., and McKay A. Resistance of Aeromonas salmonicida to oxolinic acid. Aquaculture 61 (1987) 165-171
13. Huys G., Cnockaert M., Bartie K., Oanh D.T.H., Phuong N.T., Somsiri T., Chinabut S., Yussoff F.M., Shariff M., Giacomini M., Bertone S., Swings J., and Teale A. Intra- and inter-laboratory performance of antibiotic disk-diffusion-susceptibility testing of bacterial control strains of relevance for monitoring aquaculture environments. Diseases of Aquatic Oganisms 66 (2005) 197-204
14. Izumi S., and Aranishi F. Relationship between gyrA mutations and quinolone resistance in Flavobacterium psychrophilum isolates. Applied and Environmental Microbiology 70 (2004) 3968-3972
15. Jacoby G.A., Chow N., and Waites K.B. Prevalence of plasmid-mediated quinolone resistance. Antimicrobial Agents and Chemotherapy 47 (2003) 559-562
16. Joneberg J., Rylander M., Galas M.F., Carlos C., and Kronvall G. Analysis of parameters and validation of method for normalized interpretation of antimicrobial resistance. International Journal of Antimicrobial Agents 21 (2003) 525-535
17. Kahlmeter G., Brown D.F.J., Goldstein F.W., MacGowan A.P., Mouton J.W., Österlund A., Rodloff A., Steinbakk M., Urbaskova P., and Vatopoulos A. European harmonization of MIC breakpoints for antimicrobial susceptibility testing of bacteria. Journal of Antimicrobial Chemotherapy 52 (2003) 145-148
18. Kim E.H., and Aoki T. Sequence analysis of the florfenicol resistance gene encoded in the transferable R-plasmid of a fish pathogen Pasteurella piscicida. Microbiology and Immunology 9 (1996) 665-669
19. Kim M.-J., Hirono I., and T Aoki T. Detection of quinolone-resistance genes in Photobacterium damselae subsp. piscicida strains by targeting-induced local lesions in genomes. Journal of Fish Diseases 28 (2005) 463-471
20. Kronvall G. Determination of the real standard distribution of susceptible strains in zone histograms. International Journal of Antimicrobial Agents 22 (2003) 7-13
21. Kronvall G., and Ringertz S. Antibiotic disk diffusion testing revisited. Single-strain regression analysis. Acta Pathologica, Microbiologica et Immunologica Scandinavica 99 (1991) 295-306
22. Kronvall G., Ringertz S., Karlson I., Göransson E., and Dornbusch K. Laboratory- and species-specific interpretive breakpoints for disc diffusion tests of chloramphenicol susceptibility of Haemophilus influenzae. Antimicrobial Agents and Chemotherapy 32 (1988) 1484-1489
23. Kronvall G., Kahlmeter G., Myhre E., and Galas M.F. A new method for normalized interpretation of antimicrobial resistance from disk test results for comparative purposes. Clinical Microbiology and Infection 9 (2003) 120-132
24. MacGowan A.P., and Wise R. Establishing MIC breakpoints and the interpretation of in vitro susceptibility tests. Journal of Antimicrobial Chemotherapy 48 Suppl. S1 (2001) 17-28
25. Manninen R., Eerola E., and Huovinen P. Disk diffusion susceptibility tests; need for laboratory-specific breakpoints. Scandinavian Journal of Infectious Disease 27 (1995) 45-49
26. Manninen R., Leinonen M., Huovinen P., Nissinen A., and and the Finnish Group for Antimicrobial Resistance. Reliability of disc diffusion susceptibility testing of Streptococcus pneumoniae and adjustment of laboratory-specific breakpoints. Journal of Antimicrobial Chemotherapy 41 (1998) 19-26
27. Miller A., and Reimschuessel R. Epidemiological cutoff values for antimicrobial agents against Aeromonas salmonicida isolates determined by frequency distributions of minimal inhibitory concentration and diameter of zone of inhibition data. American Journal of Veterinary Research 67 (2006) 1837-1843
28. NicGabhainn S., Amedeo M., Bergh O., Dixon B., Donachie L., Carson J., Coyne R., Curtin J., Dalsgaard I., Maxwell G., and Smith P. The precision and robustness of published protocols for disc diffusion assays of antimicrobial agent susceptibility: an inter-laboratory study. Aquaculture 240 (2003) 1-18
29. O'Grady P., Palmer R., Rodger H., and Smith P. Isolation of Aeromonas salmonicida strains resistant to the quinolone antibiotics. Bulletin of the European Association of Fish Pathologists 7 (1987) 43-46
30. Oppegaard H., and Sørum H. GyrA mutations in quinolone-resistant isolates of the fish pathogen Aeromonas salmonicida. Antimicrobial Agents and Chemotherapy 38 (1994) 2460-2464
31. Rodriguez-Avial I., Rodriguez-Avial C., Lopez O., and Picazo J.J. Trends in nalidixic acid resistance in nontyphoidal Salmonella isolated from 1999 to 2002: decreased susceptibility to 6 fluoroquinolones. Diagnostic Microbiology and Infectious Disease 52 (2005) 261-264
32. Smith P. Breakpoints for disc diffusion susceptibility testing of bacteria associated with fish diseases: A review of current practice. Aquaculture 261 (2006) 1113-1121
33. Smith P., and Hiney M. Towards setting breakpoints for oxolinic acid susceptibility of Aeromonas salmonicida using distribution of data generated by standard test protocols. Aquaculture 250 (2005) 22-26
34. Smith P., and O'Grady P. Laboratory studies of the clinical significance of disc diffusion data for oxolinic acid against Aeromonas salmonicida. Bulletin of the European Association of Fish Pathologists. 26 (2006) 229-230
35. Smith, P., Ruane, N., Douglas, I., Carroll, C., Fleming, G.T.A. (in press). Impact of inter-lab variation on the estimation of epidemiological cut-off values for disc diffusion susceptibility test data for Aeromonas salmonicida. Aquaculture.
36. Sørum H. Antimicrobial drug resistance in fish pathogens. In: Aarestrup F.M. (Ed). Antimicrobial Resistance in Bacteria of Animal Origin (2006), American Society for Microbiology Press, Washington, DC, USA 213-238
37. Turnidge J., and Paterson D.L. Setting and revising antibacterial susceptibility breakpoints. Clinical Microbiology Reviews 20 (2007) 391-408
38. WHO. Use of quinolones in food animals and potential impact on human health. Report of a WHO Meeting, Geneva, June, 1998 (1998), World HealthOrganization whqlibdoc.who.int/hq/1998/WHO_EMC_ZDI_98.10.pdf Consulted 22/11/06
39. Woods S.C., McCashion R.N., and Lynch W.H. Multiple low-level antibiotic resistance in Aeromonas salmonicida. Antimicrobial Agents and Chemotherapy 29 (1986) 992-996